Revolade 25 mg / 50 mg Tablets (Eltrombopag): Uses, Benefits and Side Effects

Revolade 25 mg and Revolade 50 mg tablets contain eltrombopag, a medicine belonging to the class of thrombopoietin receptor agonists. It helps stimulate platelet production in the bone marrow, increasing platelet counts in eligible patients with certain blood disorders.

Platelets play an important role in blood clotting. Low platelet counts, known as thrombocytopenia, may increase the risk of bruising and bleeding. Revolade is a prescription medicine used for specific conditions, including immune thrombocytopenia (ITP), severe aplastic anaemia and, in certain circumstances, thrombocytopenia associated with chronic hepatitis C. Approved indications vary by country and patient group.

Cordium Pharmaceuticals Pvt Ltd provides pharmaceutical product information for healthcare professionals, distributors and international pharmaceutical buyers seeking information about Revolade 25 mg and 50 mg tablets.

Uses and Benefits of Revolade (Eltrombopag)

Eltrombopag supports platelet production and may help manage low platelet counts when prescribed for an approved indication.

Key therapeutic uses include:

Immune thrombocytopenia (ITP): Helps increase platelet counts in eligible patients who have not responded adequately to previous treatments.

Severe aplastic anaemia: May be prescribed as part of treatment for selected patients with this bone marrow disorder.

Hepatitis C-associated thrombocytopenia: In certain settings, it has been used to manage low platelet counts associated with chronic hepatitis C treatment.

The potential benefits include improved platelet counts and reduced bleeding risk in appropriate patients. Treatment response varies, and Revolade does not cure the underlying condition. Regular medical monitoring is essential.

Possible Side Effects of Revolade

Like other prescription medicines, Revolade may cause side effects. Commonly reported effects include:

Nausea, diarrhoea or vomiting

Headache and fatigue

Fever or cough

Changes in liver enzyme levels

Muscle or back pain

Anaemia or skin rash

Important safety information: Eltrombopag may cause liver injury and increase the risk of blood clots. Patients require appropriate liver-function tests and regular blood-count monitoring. Seek urgent medical attention for symptoms such as yellowing of the skin or eyes, severe abdominal pain, chest pain, sudden breathlessness or swelling and pain in one leg.

Inform your healthcare professional about existing liver conditions, other medicines, supplements and pregnancy or breastfeeding before starting treatment.

Frequently Asked Questions (FAQs)

1. What is Revolade 25 mg used for?

Revolade 25 mg contains eltrombopag and may be prescribed for specific conditions involving low platelet counts, depending on the patient's diagnosis and local prescribing guidelines.

2. What is Revolade 50 mg used for?

Revolade 50 mg contains the same active ingredient in a higher tablet strength. The prescribed strength depends on the indication, platelet response, medical history and clinician's assessment.

3. Is Revolade the same as eltrombopag?

Revolade is a brand name, while eltrombopag is its active ingredient.

4. How should Revolade tablets be taken?

Take the medicine exactly as prescribed. Food and mineral-containing products can affect absorption, so follow the product leaflet and your healthcare professional's instructions regarding meals, calcium, iron, antacids and supplements.

5. Does Revolade require regular monitoring?

Yes. Platelet counts and liver function generally require monitoring during treatment, with the schedule determined by the prescribing clinician.

Pharmaceutical Product Information from Cordium Pharmaceuticals Pvt Ltd

Cordium Pharmaceuticals Pvt Ltd shares product information for Revolade 25 mg and 50 mg tablets (eltrombopag) for international pharmaceutical enquiries. Healthcare professionals and authorised pharmaceutical buyers may contact the company for product availability, packaging details and applicable export requirements. Supply is subject to prescription rules, product registration and import regulations in the destination country.

Medical disclaimer: This webpage is for general informational purposes only and is not a substitute for professional medical advice. Revolade should be used only under appropriate medical supervision and in accordance with locally approved prescribing information.